Denali Therapeutics Announces Upcoming Presentations on Hunter Syndrome (MPS II) and TransportVehicle™ Enabled Investigational Therapeutic Tividenofusp Alfa at the 2025 WORLDSymposium™
GlobeNewswire· 2025-01-30 13:00
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), today announced upcoming oral (platform) and poster presentations at the 21st Annual WORLDSymposium™, which will be held February 3-7, 2025, in San Diego, California. The oral presentation includes clinical results related to its Hunter syndrome (MPS II) investigational therapeutic, tividenofusp alfa (DNL310). Tividenofusp alfa is enabled by the Denali TransportVehicle™ platform, which is designed to effe ...
Global Li-Ion Updates Shareholders on Ambato-Arana Graphite Mine
GlobeNewswire· 2025-01-30 13:00
Vancouver, British Columbia, Canada, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Global Li-Ion Graphite Corp. (“Global Li-Ion” or, the “Company”) (CSE: LION, OTCQB: GBBGF, F: 0TD ) would like to take this opportunity to further update its shareholders and interested parties. The Company welcomes the confirmation by the Government of Madagascar of the importance the country’s mining industry, including graphite projects, to the nation’s development. The Implementation Procedures for a new revised Mining Code have been ...
NevGold Samples 3.79% Copper and 1.6 g/t Gold And Identifies New Copper Targets At The Zeus Copper Project in The Hercules Copper District, Idaho
GlobeNewswire· 2025-01-30 13:00
Vancouver, British Columbia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has identified additional high-grade copper, gold, and silver mineralization at surface at the Zeus Copper Project in the emerging Hercules Copper District of southwestern Idaho. The additional positive sampling results highlight the significant copper porphyry potential at the Zeus Copper Project. As detailed in NevGold’s News Rel ...
Fireweed Grants Stock Options
GlobeNewswire· 2025-01-30 13:00
VANCOUVER, British Columbia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQX: FWEDF) announces that pursuant to the Company’s stock option plan, it granted stock options today, exercisable into 2,595,000 common shares in the Company to certain officers, employees, and consultants of the Company. The stock options are exercisable at a price of C$1.48 per share for a five-year term. About Fireweed Metals Corp. Fireweed is an exploration company focused o ...
Portman Ridge Finance Corporation and Logan Ridge Finance Corporation Enter into Merger Agreement
GlobeNewswire· 2025-01-30 13:00
Portman Ridge Finance Corporation and Logan Ridge Finance Corporation Enter into Merger Agreement Combined Entity Will be Managed by Sierra Crest Investment Management, LLC, an Affiliate of BC Partners Advisors L.P. Companies to Host a Joint Conference Call on January 30, 2025, at 4:00 PM ET to Discuss the Proposed Merger NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (NASDAQ: PTMN) (“Portman Ridge” or “PTMN”) and Logan Ridge Finance Corporation (NASDAQ: LRFC) (“Logan Ridge” o ...
Treace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression Implant
GlobeNewswire· 2025-01-30 13:00
PONTE VEDRA, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced the successful completion of the first cases utilizing its SpeedAkin™ Anatomic Compression Implant. The SpeedAkin™ implant broadens the procedural versatility of Treace’s flagsh ...
Gabelli Funds to Host Pump, Valve & Water Systems Symposium at the Harvard Club, New York City
GlobeNewswire· 2025-01-30 13:00
GREENWICH, Conn., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds is hosting its 35th annual Pump, Valve & Water Systems Symposium at the Harvard Club in New York City on Thursday, February 27, 2025. The symposium focuses on themes crucial to this industry, including infrastructure spending, resource security, conservation, and mergers and acquisitions (M&A). Attendees will have the opportunity to engage in one-on-one sessions with management, providing an opportunity to delve into the strategies and growth ...
Element Launches Risk Solutions Offering with Insurance
GlobeNewswire· 2025-01-30 13:00
Element Risk Solutions, which will be available in the United States and Canada, combines insurance coverage placement with industry-leading claims management and advisory services. TORONTO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Element Fleet Management Corp. (TSX:EFN) ("Element" or the "Company"), the largest publicly traded, pure-play automotive fleet manager in the world, today announces the launch of Element Risk Solutions - a fully integrated risk management offering. This new service, which Element is lau ...
Cogent Biosciences to Participate in the Guggenheim Biotech Conference
GlobeNewswire· 2025-01-30 13:00
WALTHAM, Mass. and BOULDER, Colo., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its participation in a fireside chat at the Guggenheim SMID Cap Biotech Conference in New York on Wednesday, February 5, 2025 at 9:30 a.m. ET. A live webcast can be accessed on the Investors & Media page of Cogent’s website at https://investors.cogentbio.com/events. A replay will be av ...
Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics
GlobeNewswire· 2025-01-30 13:00
LONDON, Ontario and BOSTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell Pouch bio-hybrid organ as a functional cure for Type 1 diabetes (T1D), today announced the appointment of Ross Haghighat as Chair of the Board. With a proven track record in driving successful innovations, strategic growth and mergers and acquisitions in the biotechnology and life sciences sectors, Mr. Haghig ...